BRIEF published on 02/11/2026 at 07:05, 3 hours 59 minutes ago SCHOTT Pharma annonce un bon début d'année 2026 SCHOTT Pharma Augmentation Des Revenus Croissance De L'EBITDA Exercice Financier 2026 Solutions De Confinement Des Médicaments
BRIEF published on 02/11/2026 at 07:05, 3 hours 59 minutes ago SCHOTT Pharma Reports a Strong Beginning to 2026 Revenue Increase SCHOTT Pharma EBITDA Growth Financial Year 2026 Drug Containment Solutions
PRESS RELEASE published on 02/11/2026 at 07:00, 4 hours 4 minutes ago SCHOTT Pharma with positive start to financial year 2026; outlook confirmed SCHOTT Pharma reports positive Q1 results for 2026 with revenue growth and increased EBITDA margin. Outlook confirmed for the year Revenue Growth EBITDA Margin SCHOTT Pharma Q1 Results 2026 Outlook
BRIEF published on 02/03/2026 at 15:05, 7 days 19 hours ago Toutes les résolutions ont été adoptées lors de l'assemblée générale annuelle de SCHOTT Pharma. Actionnaires Dividende Resolutions Assemblée Générale Annuelle Pharmaceutique
BRIEF published on 02/03/2026 at 15:05, 7 days 19 hours ago All Resolutions Passed at SCHOTT Pharma's AGM Shareholders Dividend Pharmaceutical AGM Resolutions
PRESS RELEASE published on 02/03/2026 at 15:00, 7 days 20 hours ago Successful Annual General Meeting for SCHOTT Pharma: All resolutions approved SCHOTT Pharma AG & Co. KGaA had a successful Annual General Meeting with all resolutions approved, including a dividend of 0.18 EUR per share for fiscal year 2025 Annual General Meeting Shareholders Dividend SCHOTT Pharma Resolutions
BRIEF published on 12/11/2025 at 07:05, 2 months ago SCHOTT Pharma Achieves Full-Year Revenue and Profitability Targets Revenue Growth EBITDA Margin SCHOTT Pharma Drug Delivery Systems Drug Containment Solutions
BRIEF published on 12/11/2025 at 07:05, 2 months ago SCHOTT Pharma atteint ses objectifs de chiffre d'affaires et de rentabilité pour l'exercice complet. SCHOTT Pharma Croissance Des Revenus Marge D'EBITDA Systèmes D'administration De Médicaments Solutions De Confinement Des Médicaments
PRESS RELEASE published on 12/11/2025 at 07:00, 2 months ago SCHOTT Pharma delivers on full-year revenue and profitability targets SCHOTT Pharma met full-year revenue and profitability targets, with revenue growing by 5.8% and EBITDA margin at 28.4%. Fiscal year 2026 guidance: 2-5% revenue growth and 27% EBITDA margin Revenue Growth EBITDA Margin SCHOTT Pharma Profitability Targets Fiscal Year 2026
BRIEF published on 12/04/2025 at 19:15, 2 months 6 days ago SCHOTT Pharma Reports Preliminary 2025 Financial Results EBITDA Margin Mid-term Guidance Drug Delivery Systems Preliminary Results 2025 Financial Forecast 2026
Published on 02/11/2026 at 06:00, 5 hours 4 minutes ago Tocvan Announces Restart Of Exploration Drilling At The Gran Pilar Project South Block
Published on 02/11/2026 at 03:05, 7 hours 59 minutes ago CANEX Metals Announces Final Take Up of Gold Basin Shares and Expiry of Successful Gold Basin Offer
Published on 02/11/2026 at 01:00, 10 hours 4 minutes ago Kidoz Inc. Appoints John Nolie as Vice President of Sales, North America
Published on 02/10/2026 at 22:50, 12 hours 14 minutes ago Tectonic Metals Announces Financing of up to $40 Million
Published on 02/10/2026 at 22:15, 12 hours 49 minutes ago Earthwise Minerals Completes Private Placement and Makes Changes to the Management Team
Published on 02/11/2026 at 10:52, 11 minutes ago Personnel News: REPLOID Group AG expands Director-level leadership team with Andreas Steinbüchler
Published on 02/11/2026 at 10:05, 58 minutes ago Fractus expands U.S. connected safety licensing via RPX agreement
Published on 02/11/2026 at 10:01, 1 hour 3 minutes ago Salzgitter Group boosts defense portfolio and takes over Thyrolf & Uhle
Published on 02/11/2026 at 10:00, 1 hour 4 minutes ago PL BioScience Wins Regulatory Certification from Japan’s PMDA
Published on 02/11/2026 at 10:00, 1 hour 4 minutes ago Rentschler Biopharma appoints Dr. Veit Bergendahl as Chief Operating Officer and member of the executive board
Published on 02/11/2026 at 08:00, 3 hours 4 minutes ago Imerys-press-release French State acquisition stake Emili Lithium
Published on 02/11/2026 at 08:00, 3 hours 4 minutes ago Imerys-communique-de-presse prise participation Etat Français Projet lithium Emili
Published on 02/10/2026 at 18:24, 16 hours 39 minutes ago Mersen: Number of shares and voting rights as of January 31, 2026
Published on 02/10/2026 at 18:24, 16 hours 39 minutes ago Mersen : nombre d'actions et de droits de vote au 31 janvier 2026
Published on 02/10/2026 at 18:00, 17 hours 4 minutes ago CIS remporte plusieurs contrats stratégiques en Afrique, en Amérique du Sud et en Asie
